Notice of approval ad

Launch ad

Click on the images to see the full-sized ads and get all the info on AdPharm.

Over 2,000 more healthcare professional ads on AdPharm, click here

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

Charlie Kimball is a successful race-car driver who was diagnosed with Type 1 diabetes in 2007. He was forced to stop racing mid-season following this. This elaborate social media marketing effort aims to show diabetes suffers that even with diabetes, they can accomplish great things. Charlie resumed racing in 2008 and continues to claim podiums. Novo Nordisk teamed-up with Charlie in this effort to promote Levemir and Novolog brands of insulin.

This effort includes a Facebook fan page, a YouTube Channel, a Twitter account, a blog and a specific page on Novo Nordisk Care’s Website.

Click here to view the campaign details, full-size versions and links on AdPharm

Today, I took steps to balance my type 2 diabetes.
Today, I chose salad and talked to my doctor.

It’s time. Crestor

Call 1-888-JANUVIA or visit Januvia.com

A different way. Januvia.

Sitagliptin (INN; previously identified as MK-0431, trade name Januvia) is an oral antihyperglycemic (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class, Sitagliptin being the only 2nd Generation DPP4 inhibitor currently available. This enzyme-inhibiting drug is used either alone or in combination with other oral antihyperglycemic agents (such as metformin or a thiazolidinedione) for treatment of diabetes mellitus type 2. The benefit of this medicine is its lower side-effects (e.g., less hypoglycemia, less weight gain) in the control of blood glucose values. Exenatide (Byetta) is an alternative drug that also works with the incretin system. – Wikipedia

US News and World Report February 2009